Alli 60 mg capsules: Counterfeit Product, UPDATE
There has been an update of the Alli 60 mg. capsules from the January 21 blog post. As of January 23, 2010 the FDA has been updated with information on laboratory analysis of the sibutramine levels in counterfeit product.
A series of additional FDA laboratory tests on the counterfeit product show that consumers may be taking 3-times the usual daily dose (or twice the recommended maximum dose) of sibutramine when following the dosing directions suggested by Alli.
Healthy people who take this much sibutramine can experience anxiety, nausea, heart palpitations, tachycardia (a racing heart), insomnia, and small increases in blood pressure. This excessive amount of sibutramine is dangerous to people who have a history of cardiovascular disease, and can lead to elevated blood pressure, stroke, or heart attack.
Read the MedWatch 2010 Safety summary including: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm197862.htm
For More Information, please call 1-877 MESSALAW
